210 related articles for article (PubMed ID: 8554879)
1. [Brachytherapy of ocular melanoma: physical and dosimetric aspects of 125I plaques].
Bard JJ
Bull Cancer Radiother; 1995; 82(3):295-305. PubMed ID: 8554879
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive dosimetric comparison between (131)Cs and (125)I brachytherapy sources for COMS eye plaque implant.
Zhang H; Martin D; Chiu-Tsao ST; Meigooni A; Thomadsen BR
Brachytherapy; 2010; 9(4):362-72. PubMed ID: 20116342
[TBL] [Abstract][Full Text] [Related]
3. [Development and dosimetry of a 125 iodine applicator for brachytherapy of intraocular tumors].
Alberti W; Pothmann B; Bornfeld N; Foerster MH; Harder D; Hermann KP; Muskalla K; Tabor P; Sack H; Wessing A
Fortschr Ophthalmol; 1990; 87(2):201-5. PubMed ID: 2358279
[TBL] [Abstract][Full Text] [Related]
4. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
[TBL] [Abstract][Full Text] [Related]
5. Optimization of 125I ophthalmic plaque brachytherapy.
Astrahan MA; Luxton G; Jozsef G; Liggett PE; Petrovich Z
Med Phys; 1990; 17(6):1053-7. PubMed ID: 2280735
[TBL] [Abstract][Full Text] [Related]
6. Investigating the dosimetric impact of seed location uncertainties in Collaborative Ocular Melanoma Study-based eye plaques.
Johnson JE; Deufel CL; Furutani KM
Brachytherapy; 2016; 15(5):661-8. PubMed ID: 27475484
[TBL] [Abstract][Full Text] [Related]
7. Dose rate effect of 125I irradiation on normal rabbit eyes and experimental choroidal melanoma.
Yang CM; Olsen KR; Schwade JG; Houdek PV; Markoe AM; Pisciotta V; Wu X
Exp Eye Res; 1993 Nov; 57(5):577-85. PubMed ID: 8282044
[TBL] [Abstract][Full Text] [Related]
8. 125I eye plaque dose distribution including penumbra characteristics.
de la Zerda A; Chiu-Tsao ST; Lin J; Boulay LL; Kanna I; Kim JH; Tsao HS
Med Phys; 1996 Mar; 23(3):407-18. PubMed ID: 8815384
[TBL] [Abstract][Full Text] [Related]
9. The impact of prescription depth, dose rate, plaque size, and source loading on the central axis using 103Pd, 125I, and 131Cs.
Rivard MJ; Melhus CS; Sioshansi S; Morr J
Brachytherapy; 2008; 7(4):327-35. PubMed ID: 18782684
[TBL] [Abstract][Full Text] [Related]
10. Improved treatment planning for COMS eye plaques.
Astrahan MA
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1227-42. PubMed ID: 15752905
[TBL] [Abstract][Full Text] [Related]
11. Dosimetry and design of radioactive eye plaques.
Flühs D; Bambynek M; Heintz M; Indenkämpen F; Kolanoski H; Wegener D; Sauerwein W; Quast U
Front Radiat Ther Oncol; 1997; 30():26-38. PubMed ID: 9205882
[No Abstract] [Full Text] [Related]
12. Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques.
Puusaari I; Heikkonen J; Kivelä T
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3425-34. PubMed ID: 15452045
[TBL] [Abstract][Full Text] [Related]
13. Modified COMS plaques for 125I and 103Pd iris melanoma brachytherapy.
Thomson RM; Furutani KM; Pulido JS; Stafford SL; Rogers DW
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1261-9. PubMed ID: 20472360
[TBL] [Abstract][Full Text] [Related]
14. Computer assisted treatment planning for 125I ophthalmic plaque radiotherapy.
Ling CC; Chen GT; Boothby JW; Weaver K; Stuart A; Barnett C; Char D; Phillips TL
Int J Radiat Oncol Biol Phys; 1989 Aug; 17(2):405-10. PubMed ID: 2753765
[TBL] [Abstract][Full Text] [Related]
15. 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view.
Nickers P; Thissen B; Jansen N; Deneufbourg JM
Radiother Oncol; 2006 Jan; 78(1):47-52. PubMed ID: 16216365
[TBL] [Abstract][Full Text] [Related]
16. Palladium-103 plaque radiotherapy for choroidal melanoma: results of a 7-year study.
Finger PT; Berson A; Szechter A
Ophthalmology; 1999 Mar; 106(3):606-13. PubMed ID: 10080222
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric calculations and measurements of gold plaque ophthalmic irradiators using iridium-192 and iodine-125 seeds.
Luxton G; Astrahan MA; Liggett PE; Neblett DL; Cohen DM; Petrovich Z
Int J Radiat Oncol Biol Phys; 1988 Jul; 15(1):167-76. PubMed ID: 3391814
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric study of the 15 mm ROPES eye plaque.
Granero D; Pérez-Calatayud J; Ballester F; Casal E; de Frutos JM
Med Phys; 2004 Dec; 31(12):3330-6. PubMed ID: 15651616
[TBL] [Abstract][Full Text] [Related]
19. Delivered dose uncertainty analysis at the tumor apex for ocular brachytherapy.
Morrison H; Menon G; Larocque MP; Jans HS; Weis E; Sloboda RS
Med Phys; 2016 Aug; 43(8):4891. PubMed ID: 27487906
[TBL] [Abstract][Full Text] [Related]
20. Monte Carlo dosimetry of the eye plaque design used at the St. Erik Eye Hospital for (125)I brachytherapy.
Karlsson M; Nilsson J; Lundell M; Carlsson Tedgren A
Brachytherapy; 2014; 13(6):651-6. PubMed ID: 24950821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
